Popular Articles
Wind Point taps $1.2bn-targeting Fund IX for Tropicale Foods buyout
Wind Point Partners has tapped the $1.2bn-targeting Fund IX it is currently raising to make an investment in frozen novelty products business Tropicale Foods.
Minnesota SBI said to line up almost $1bn for alternatives
The Minnesota State Board of Investments has reportedly committed $950m to a number of alternative asset funds managed by Leonard Green & Partners and Vista Equity, among others.
BlackRock PE veteran Wiseman sacked over relationship with colleague
Mark Wiseman, a private equity industry veteran, was an executive being groomed for the top job at BlackRock, before being sacked this week for an undisclosed relationship with a co-worker.
Ex-New York Life CIO seeks $200m for new FinTech VC fund
Former New York Life Insurance president and chief investment officer John Kim is looking to raise $200m for a new FinTech venture fund.
Apollo appoints ex-Bain Capital MD to lead Japanese PE unit
Apollo Global Management has named former Bain Capital exec Tetsuji Okamoto as a partner and head of its Japanese private equity business.
PennSERS picks Clearlake, Insight megafunds for $150m of new PE commitments
The $29.6bn-managing Pennsylvania State Employees’ Retirement System has revealed another $150m of private equity investments.
Amundi reveals new €500m private equity program targeting Eurozone SMEs
French asset manager Amundi's private equity arm has launched a €500m investment program targeting European SMEs.
TCV brings in Providence Equity Partners’ Gopi Vaddi as newest general partner
TCV has swooped for Providence Equity Partners managing director Gopi Vaddi as its latest general partner.
DOB Equity looks to aid Tanzanian vanilla growing boom with NEI investment
Africa-focused impact investor DOB Equity has bought Tanzanian natural vanilla flavour maker Natural Extracts Industries.
Kaiser Permanente Ventures brings AUM to over $500m with latest healthcare fund close
Kaiser Permanente Ventures has hit a $141m final close for its fifth fund targeting growth businesses aiming to address unmet medical needs in the US healthcare system.
